Details for New Drug Application (NDA): 050636
✉ Email this page to a colleague
NDA 050636 describes CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, which is a drug marketed by Abraxis Pharm, Hikma, Abbott Labs, and Baxter Hlthcare, and is included in five NDAs. It is available from one supplier. Additional details are available on the CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% profile page.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
The generic ingredient in CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for 050636
| Tradename: | CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% |
| Applicant: | Abraxis Pharm |
| Ingredient: | clindamycin phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 12MG BASE/ML | ||||
| Approval Date: | Dec 22, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
